🇺🇸 FDA
Patent

US 9295659

High dose extended-release potassium citrate wax matrix tablet

granted A61KA61K31/194A61K9/2013

Quick answer

US patent 9295659 (High dose extended-release potassium citrate wax matrix tablet) held by UNITED LABORATORIES, INC. expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNITED LABORATORIES, INC.
Grant date
Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/194, A61K9/2013, A61K9/2077, A61K9/2095